Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12458
Peer-review started: September 15, 2022
First decision: September 27, 2022
Revised: October 6, 2022
Accepted: November 2, 2022
Article in press: November 2, 2022
Published online: November 26, 2022
Processing time: 69 Days and 6.3 Hours
Autoimmune pancreatitis (AIP) is a special type of chronic pancreatitis mediated by autoimmunity factors. It can be divided into two categories according to pathological characteristics: Lymphoplasmacytic sclerosing pancreatitis and idiopathic duct-centric pancreatitis. In the clinical setting, the imaging manifestations of some AIP cases are atypical, so it is difficult to distinguish it from general pancreatitis, pancreatic ductal adenocarcinoma, lymphoma, and other malignant disorders. Most importantly, the treatment for and prognosis of these diseases are different. Therefore, a timely correct imaging diagnosis of AIP is key for AIP patients. After that, clinicians can take appropriate treatment measures for those patients, which is helpful for the prognosis of AIP.
Core Tip: Autoimmune pancreatitis (AIP) is a special form of chronic pancreatitis mediated by autoimmunity. Because the clinical presentation is not specific, the progress of imaging diagnosis and differential diagnosis of AIP may increase the awareness of AIP among clinicians. Timely intervention is very good for AIP patients. Clinicians can adopt the effective method in the early course of the disease. We propose five related research directions in this paper. We hope that the clinical work and scientific research can start from these aspects in the future. AIP patients will benefit from continuous exploration of imaging differential diagnosis and prognosis assessment of AIP.